RT Journal Article
SR Electronic
T1 Severe Raynaud's phenomenon with yohimbine therapy for erectile dysfunction.
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP 2503
OP 2505
VO 30
IS 11
A1 Johnson, Sindhu
A1 Iazzetta, John
A1 Dewar, Catharine
YR 2003
UL http://www.jrheum.org/content/30/11/2503.abstract
AB Yohimbine is a selective alpha-2 adrenergic antagonist that has been used in the pharmacologic management of erectile dysfunction (ED). We describe a patient with CREST syndrome (calcinosis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly, and telangiectasia) who paradoxically experienced worsening of Raynaud's phenomenon when using yohimbine for ED.